Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 4Colonic Neoplasms 4Pain, Postoperative 3Pancreatic Neoplasms 2Pain 2Neoplastic Cells, Circulating 2Agnosia 2Stomach Neoplasms 1Rectal Neoplasms 1Neoplasms 1Neoplasm, Residual 1Neoplasm Metastasis 1Liver Neoplasms 1Inflammatory Bowel Diseases 1Inflammation 1Ileus 1Diverticulosis, Colonic 1Diverticulitis, Colonic 1Diverticulitis 1Constipation 1Carcinoma, Hepatocellular 1

Interventions

Blood Specimen Collection 4Liquid Biopsy 2trastuzumab deruxtecan 1tislelizumab 1fludarabine phosphate 1fludarabine 1Pirinitramide 1Oxaliplatin 1Neoadjuvant Therapy 1Morphine 1Leucovorin 1Irinotecan 1HMPL-013 1Folfox protocol 1Fluorouracil 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Cetuximab 1Analgesia, Epidural 1AP 1903 reagent 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neoplasm, Residual × Morphine × Gastrointestinal × Clear all
NCT02314871 2019-03-13

Effects of Different Types of Perioperative Analgesia on Minimal Residual Disease Development After Colon Cancer Surgery

The Institute of Molecular and Translational Medicine, Czech Republic

Phase 4 Completed
60 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms, Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡